A Consecutive Ring-Expansion Strategy towards the Macrocyclic Core of the Solomonamide Natural Products

Abstract

A synthetic strategy based on the application of three consecutive ring-expansion reactions has been used in the synthesis of analogues of the macrocyclic core of the solomonamide natural products. Starting from a simple, readily available tetrahydrocarbazole, oxidative ring expansion is followed by two further 3- and 4-atom ring-expansion reactions, enabling the insertion of amino acid and hydroxy acid derived linear fragments into 15- to 17-membered-ring-enlarged macrocyclic products.

Key words

macrocycles - medium-sized rings - ring expansion - natural product analogues - lactams - lactones - solomonamides

Publikationsverlauf

Eingereicht: 21. Juli 2022

Angenommen nach Revision: 29. August 2022

Accepted Manuscript online:
29. August 2022

Artikel online veröffentlicht:
30. September 2022

• References and Notes

• 1 Since completing this study, C. R. B. Swanson has relocated to a different institution: Manchester Institute of Biotechnology, The University of Manchester, 131 Princess Street, Manchester, M1 7DN (UK).
• 2 Festa C, De Marino S, Sepe V, D’Auria MV, Bifulco G, Débitus C, Bucci M, Vellecco V, Zampella A. Org. Lett. 2011; 13: 1532
• 3 Kashinath K, Jachak GR, Athawale PR, Marelli UK, Gonnade RG, Reddy DS. Org. Lett. 2016; 18: 3178
• 4 Jachak GR, Athawale PR, Agarwal H, Barthwal MK, Lauro G, Bifulco G, Reddy DS. Org. Biomol. Chem. 2018; 16: 9138
• 5a Kashinath K, Vasudevan N, Reddy DS. Org. Lett. 2012; 14: 6222
• 5b Vasudevan N, Kashinath K, Reddy DS. Org. Lett. 2014; 16: 6148
• 5c Kashinath K, Dhara S, Reddy DS. Org. Lett. 2015; 17: 2090
• 5d Jachak GR, Athawale PR, Choudhury R, Kashinath K, Reddy DS. Chem. Asian J. 2019; 14: 4572
• 6a Kavitha N, Kumar VP, Chandrasekhar S. Tetrahedron Lett. 2013; 54: 2128
• 6b Kavitha N, Chandrasekhar S. Org. Biomol. Chem. 2015; 13: 6242
• 6c Cheng-Sánchez I, García-Ruiz C, Sarabia F. Tetrahedron Lett. 2016; 57: 3392
• 6d Cheng-Sánchez I, Carrillo P, Sánchez-Ruiz A, Martínez-Poveda B, Quesada AR, Medina M. Á, López-Romero JM, Sarabia F. J. Org. Chem. 2018; 83: 5365
• 6e Carrillo P, Martínez-Poveda B, Cheng-Sánchez I, Guerra J, Tobia C, López-Romero JM, Sarabia F, Medina MA, Quesada AR. Mar. Drugs 2019; 17: 228
• 7 Saridakis I, Kaiser D, Maulide N. ACS Cent. Sci. 2020; 6: 1869
• 8 Practical Medicinal Chemistry with Macrocycles. Marsault E, Peterson ML. Wiley; Hoboken: 2017
• 9a Gradillas A, Pérez-Castells J. Angew. Chem. Int. Ed. 2006; 45: 6086
• 9b Lecourt C, Dhambri S, Allievi L, Sanogo Y, Zeghbib N, Ben Othman R, Lannou M.-I, Sorin G, Ardisson J. Nat. Prod. Rep. 2018; 35: 105

For papers discussing the influence of ring size on end-to-end cyclisation reactions, see:
• 10a Illuminati G, Mandolini L. Acc. Chem. Res. 1981; 14: 95
• 10b Fastrez J. J. Phys. Chem. 1989; 93: 2635
• 10c Collins JC, James K. Med. Chem. Commun. 2012; 3: 1489
• 10d Kurouchi H, Ohwada T. J. Org. Chem. 2020; 85: 876

For general perspective on macrocycle synthesis, see:
• 10e Marsault E, Peterson ML. J. Med. Chem. 2011; 54: 1961
• 10f Yudin AK. Chem. Sci. 2015; 6: 30
• 10g Mortensen KT, Osberger TJ, King TA, Sore HF, Spring DR. Chem. Rev. 2019; 119: 10288
• 10h Appavoo SD, Huh S, Diaz DB, Yudin AK. Chem. Rev. 2019; 119: 9724
• 10i Smolyar IV, Yudin AK, Nenajdenko VG. Chem. Rev. 2019; 119: 10032
• 11 For a review on consecutive ring-expansion reactions, see: Stephens TC, Unsworth WP. Synlett 2020; 31: 133

For reviews on ring expansion, see:
• 12a Hesse M. In Ring Enlargement in Organic Chemistry. Wiley-VCH; Weinheim: 1991
• 12b Unsworth WP, Donald JR. Chem. Eur. J. 2017; 23: 8780
• 12c Prantz K, Mulzer J. Chem. Rev. 2010; 110: 3741
• 12d Clarke AK, Unsworth WP. Chem. Sci. 2020; 11: 2876

For selected recent examples, see:
• 13a Li L, Li Z.-L, Wang F.-L, Guo Z, Cheng Y.-F, Wang N, Dong X.-W, Fang C, Liu J, Hou C, Tan B, Liu X.-Y. Nat. Commun. 2016; 7: 13852
• 13b Mendoza-Sanchez R, Corless VB, Nguyen QN. N, Bergeron-Brlek M, Frost J, Adachi S, Tantillo DJ, Yudin AK. Chem. Eur. J. 2017; 23: 13319
• 13c Costil R, Lefebvre Q, Clayden J. Angew. Chem. Int. Ed. 2017; 56: 14602
• 13d Loya DR, Jean A, Cormier M, Fressigné C, Nejrotti S, Blanchet J, Maddaluno J, De Paolis M. Chem. Eur. J. 2018; 24: 2080
• 13e Lawer A, Rossi-Ashton JA, Stephens TC, Challis BJ, Epton RG, Lynam JM, Unsworth WP. Angew. Chem. Int. Ed. 2019; 58: 13942
• 13f Grintsevich S, Sapegin A, Reutskaya E, Peintner S, Erdélyi M, Krasavin M. Eur. J. Org. Chem. 2020; 5664
• 13g Shang J, Thombare VJ, Charron CL, Wille U, Hutton C. Chem. Eur. J. 2021; 26: 1620
• 14a Kitsiou C, Hindes JJ, l’Anson P, Jackson P, Wilson TC, Daly EK, Felstead HR, Hearnshaw P, Unsworth WP. Angew. Chem. Int. Ed. 2015; 54: 15794
• 14b Baud LG, Manning MA, Arkless HL, Stephens TC, Unsworth WP. Chem. Eur. J. 2017; 23: 2225
• 14c Stephens TC, Lodi M, Steer A, Lin Y, Gill M, Unsworth WP. Chem. Eur. J. 2017; 23: 13314
• 14d Stephens TC, Lawer A, French T, Unsworth WP. Chem. Eur. J. 2018; 24: 13947
• 14e Lawer A, Epton RG, Stephens TC, Palate KY, Lodi M, Marotte E, Lamb KJ, Sangha JK, Lynam J, Unsworth WP. Chem. Eur. J. 2020; 26: 12674
• 14f Palate KY, Epton RG, Whitwood AC, Lynam JM, Unsworth WP. Org. Biomol. Chem. 2021; 19: 1404
• 14g Palate KY, Yang Z, Whitwood AC, Unsworth WP. RSC Chem. Biol. 2022; 3: 334
• 15 For the application of SuRE reactions by another research group, see: Zhao C, Ye Z, Ma Z.-X, Wildman SA, Blaszczyk SA, Hu L, Guizei IA, Tang W. Nat. Commun. 2019; 10: 4015
• 16 Dolby LJ, Booth DL. J. Am. Chem. Soc. 1966; 88: 1049

For useful perspective on how resonance and conformation can affect the reactivity of amide derivatives, see:
• 17a Liu C, Szostak M. Chem. Eur. J. 2017; 23: 7157
• 17b Li G, Ma S, Szostak M. Trends Chem. 2020; 2: 914
• 18 In the cases of products 28 and 33 (both prepared from enantiopure proteinogenic amino acids), the enantiopurity of the products was not measured in this study, but epimerisation is considered to be unlikely based on our previous studies (ref. 14), in which such epimerisation was not observed in related systems.
• 19 Representative Procedure for SuRE Method A (Synthesis of 28) 3,4,5,6-Tetrahydro-1H-(1)-benzazonin-2,7-dione 8 (406.4 mg, 2.00 mmol), DMAP (24.4 mg, 0.200 mmol), and pyridine (0.970 mL, 12.0 mmol) in dry DCM (10 mL) under an argon atmosphere were stirred at RT for 30 min. Next, a solution of acid chloride (6.0 mmol, 3.0 equiv., prepared from Cbz-proline using the procedure described in the Supporting Information) in dry DCM (10 mL) was added, and the resulting mixture was heated at reflux (50 °C) for 18 h. The solvent was then concentrated in vacuo, loaded onto a short silica plug and eluted with ethyl acetate, to remove majority of excess carboxylic acid and pyridine residues, and concentrated in vacuo. This material was redissolved in MeOH (20 mL) and placed under an argon atmosphere. Palladium on carbon (200 mg, 10% Pd on carbon) was added, and the reaction vessel was backfilled with hydrogen (via balloon) several times, then stirred at RT under a slight positive pressure of hydrogen (balloon) for 1 h. The reaction was then purged with argon, filtered through Celite, washed with methanol, and the solvent was removed in vacuo. Purification by flash column chromatography (SiO₂, ethyl acetate) afforded the title compound as a colorless oil (414 mg, 69% over 2 steps from 8) which exists as a 5:1 mixture of rotamers in solution in CDCl₃; [α]_D ²³ –312.13 (c = 1.0, CHCl₃); R_f = 0.23 (ethyl acetate). IR (neat) ν_max = 3252, 2948, 2242, 1691, 1672, 1602, 1505, 1442, 1299, 1238, 910, 756, 725, 644, 580 cm^–1. ¹H NMR (400 MHz, CDCl₃): δ = 9.43 (s, 1 H, NH, major rotamer), 9.34 (s, 1 H, NH, minor rotamer), 7.77–7.73 (m, 1 H, PhCH, major rotamer), 7.42–7.28 (m, 2 H, PhCH, both rotamers), 7.20–7.14 (m, 1 H, PhCH, minor rotamer), 7.07 (td, J = 7.6, 1.0 Hz, 1 H, PhCH, major rotamer), 4.31–4.20 (m, 1 H, NCHCO, both rotamers), 3.78 (dt, J = 10.1, 7.0 Hz, 1 H, NCH₂, major rotamer), 3.60 (ddd, J = 11.5, 7.3, 4.3 Hz, 1 H, NCH₂, minor rotamer), 3.55–3.44 (m, 1 H, NCH₂, both rotamers), 3.07–2.78 (m, 2 H, CH₂, both rotamers), 2.68–2.49 (m, 1 H, CH₂, major rotamer), 2.36–2.01 (m, 4 H, CH₂, both rotamers), 2.02–1.61 (m, 5 H, CH₂, both rotamers). ¹³C NMR (100 MHz, CDCl₃) for the major rotamer only: δ = 207.2 (CO), 173.4 (CO), 172.8 (CO), 134.8 (PhC), 133.0 (PhC), 131.4 (PhCH), 126.9 (PhCH), 124.5 (PhCH), 124.1 (PhCH), 62.6 (COCHN), 47.0 (CH₂), 41.8 (CH₂), 35.1 (CH₂), 28.4 (CH₂), 25.3 (CH₂), 22.6 (CH₂), 22.1 (CH₂). Diagnostic ¹³C NMR resonances for the minor rotamer: δ = 204.8 (CO), 172.6 (CO), 172.3 (CO), 135.9 (PhC), 133.6 (PhC), 127.9 (PhCH), 126.0 (PhCH), 125.5 (PhCH), 61.4 (COCHN), 38.5 (CH₂), 31.9 (CH₂), 31.6 (CH₂), 23.6 (CH₂), 23.0 (CH₂), 21.2 (CH₂). HRMS (ESI): m/z calcd for C₁₇H₂₀N₂NaO₃: 323.1366; found [MNa]⁺: 323.1362 (1.3 ppm error). For spectroscopic data and procedures for all novel compounds prepared in this manuscript, see the Supporting Information.